Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms
Open accessThe DOI matches its Crossref record; 136 of the 136 references it cites were found in a registry or an index; none of the 131 sources its claims cite is checked for support yet.
Abstract
Pseudomonas aeruginosa is a major cause of life-threatening acute infections and life-long lasting chronic infections. The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance, involving physical and physiological factors in addition to biofilm-specific genes that can confer a transient protection against antibiotics promoting the development of resistance. Indeed, a striking feature of this pathogen is the extraordinary capacity to develop resistance to nearly all available antibiotics through the selection of chromosomal mutations, evidenced by its outstanding and versatile mutational resistome. This threat is dramatically amplified in chronic infections, driven by the frequent emergence of mutator variants with enhanced spontaneous mutation rates. Thus, this mini review is focused on describing the complex interplay of antibiotic resistance mechanisms in P. aeruginosa biofilms, to provide potentially useful information for the design of effective therapeutic strategies.
Overview
CoChat Summary
TL;DR
This mini-review describes how *Pseudomonas aeruginosa* biofilms combine transient antibiotic tolerance mechanisms with conventional resistance mechanisms, including mutational resistance and horizontal gene transfer. It argues that biofilm physiology and population structure create a favorable environment for resistance emergence and discusses therapeutic strategies targeting biofilm-specific vulnerabilities.
Key findings
- Biofilm tolerance involves matrix binding/penetration delay, nutrient and oxygen gradients, low metabolic activity, persisters (<0.1% of the biofilm population), reduced ROS, upregulated efflux pumps, and adaptive responses such as colistin-induced *pmr*/*arn* and β-lactam-induced AmpC; these confer transient protection rather than conventional resistance.
- Conventional resistance in biofilms includes mutational resistance and horizontal gene transfer. Mutator/hypermutable strains are present in over one-third of studied cystic fibrosis patients with chronic respiratory infections, compared with 10% at chronic infection onset, 6% in the environment, and <1% in acute infections.
- Biofilm-specific gene expression contributes to resistance: *brlR* activates MexAB-oprM and MexEF-oprN efflux pumps and the ABC transporter PA1874-1877 (10 times more expressed in biofilms), and increased *brlR* lowered susceptibility to hydrogen peroxide and five different classes of antibiotics, increasing MICs up to 6-fold.
- Biofilms facilitate horizontal gene transfer via conjugation, transformation, and transduction; conjugation occurs at higher frequencies than in planktonic cultures, and biofilms can act as plasmid reserves preserving multidrug-resistance plasmids. Mixed biofilm communities also show shielding, e.g., PAO1Δ*dacB* resistant mutants were selected for and amplified under cefepime and located in outer biofilm layers surrounding sensitive PAO1.
Methods
- Design: narrative mini-review; no primary experiments or systematic review methodology are reported.
- Data or sample: published literature on *P. aeruginosa* biofilms, antibiotic tolerance/resistance mechanisms, and related in vitro, in vivo, and cystic fibrosis clinical studies; no new sample or dataset is generated.
- Main analysis: synthesis of cited studies and mechanisms, including a figure adapted from Ciofu et al., *Nat Rev*, 2022.
Limitations
- The paper states no limitations.
- Evident: as a mini-review, it lacks systematic search/selection criteria and does not report primary data or quantitative synthesis.
- Evident: its scope is restricted to *P. aeruginosa* biofilms and antibiotic resistance/tolerance mechanisms; the therapeutic strategies discussed are not clinically validated in this paper.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
0 Valid · 3 Not valid · 75 Not checked · 10 Own results and interpretations
None of the sources cited for this claim have been checked yet.
In the paper
“The characteristic biofilm mode of life in P. aeruginosa chronic infections severely limits the efficacy of antimicrobial therapies, as it leads to intrinsic tolerance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“promoting the development of resistance”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Abstract
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Due to the matrix protection, bacterial cells within a biofilm are significantly more recalcitrant to antibiotics and host immune defences than their planktonic counterparts, as shown by in vitro and in vivo evidence [[5], [6], [7], [8]].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [5] Høiby N. Ciofu O. Johansen H.K. Song Z. Moser C. Jensen P.Ø. The clinical impact of bacterial biofilms Int J Oral Sci 3 2011 55 65 10.4248/IJOS11026 21485309 PMC3469878 source
- Not checked yetcites [6] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. Pharmacokinetics/pharmacodynamics of colistin and imipenem on mucoid and nonmucoid Pseudomonas aeruginosa biofilms Antimicrob Agents Chemother 55 2011 4469 4474 10.1128/AAC.00126-11 21670181 PMC3165294 source
- Not checked yetcites [7] Hengzhuang W. Wu H. Ciofu O. Song Z. Høiby N. In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection Antimicrob Agents Chemother 56 2012 2683 2690 10.1128/AAC.06486-11 22354300 PMC3346607 source
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“which by itself is intrinsically resistant to many antibiotics”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction > Pseudomonas aeruginosa: a paradigmatic microorganism
What the sources say
- Not checked yetcites [15] Potron A. Poirel L. Nordmann P. Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology Int J Antimicrob Agents 45 2015 568 585 10.1016/j.ijantimicag.2015.03.001 25857949 source
- Not checked yetcites [16] Oliver A. Mulet X. López-Causapé C. Juan C. The increasing threat of Pseudomonas aeruginosa high-risk clones Drug Resist Updates 21–22 2015 41 59 10.1016/j.drup.2015.08.002 26304792 source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“the inability to clear the bacteria is directly related to the chronicity of the infections [9,10].”
§ Mechanisms of antibiotic resistance in Pseudomonas aeruginosa biofilms > Introduction
What the sources say
- Not checked yetcites [9] Smith E.E. Buckley D.G. Wu Z. Saenphimmachak C. Hoffman L.R. D’Argenio D.A. Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients Proc Natl Acad Sci U S A 103 2006 8487 8492 10.1073/pnas.0602138103 16687478 PMC1482519 source
- Not checked yetcites [10] Oliver A. Mena A. Maciá M.D. Evolution of Pseudomonas aeruginosa pathogenicity: from acute to chronic infections Evol. Biol. Bact. Fungal pathog 2007 John Wiley & Sons, Ltd 433 444 10.1128/9781555815639.ch36 source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
48 more claims
Create a free account to see all 88 claims and to verify the 131 references still open.
- It may state two separate claims as one. 30
- Probably not a substantial claim. 9
Citations
Cites
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167
Biofilms: an emergent form of bacterial life
Flemming, H.-C., Wingender, J., Szewzyk, U., Steinberg, P., Rice, S. A., & Kjelleberg, S. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.94 · Cited by 5,979
Biofilms as Complex Differentiated Communities
Stoodley, P., Sauer, K., Davies, D. G., & Costerton, J. W. (2002) · Annual Review of Microbiology · doi:10.1146/annurev.micro.56.012302.160705 · Cited by 3,158
How antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203 · cited 1×
“in turn activates DNA release systems further promoting said state, that also contribute to the stabilisation of the biofilm matrix [77,99,104].”
BackgroundSurvival strategies of infectious biofilms
Fux, C. A., Costerton, J. W., Stewart, P. S., & Stoodley, P. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2004.11.010 · Cited by 1,812
Bacterial biofilm and associated infections
Jamal, M., Ahmad, W., Andleeb, S., Jalil, F., Imran, M., Nawaz, M. A., Hussain, T., Ali, M., Rafiq, M., & Kamil, M. A. (2018) · Journal of the Chinese Medical Association · doi:10.1016/j.jcma.2017.07.012 · Cited by 1,642
Lung Infections Associated with Cystic Fibrosis
Lyczak, J. B., Cannon, C. L., & Pier, G. B. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.194-222.2002 · Cited by 1,628
High Frequency of Hypermutable Pseudomonas aeruginosa in Cystic Fibrosis Lung Infection
Oliver, A., Cantón, R., Campo, P., Baquero, F., & Blázquez, J. (2000) · Science · doi:10.1126/science.288.5469.1251 · Cited by 1,465
Self-citation
Cited by
Halawa, E. M., Fadel, M., Al-Rabia, M. W., Behairy, A., Nouh, N. A., Abdo, M., Olga, R., Fericean, L., Atwa, A. M., El-Nablaway, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1305294 · Cited by 280
Advanced Nanoparticles in Combating Antibiotic Resistance: Current Innovations and Future Directions
AlQurashi, D. M., AlQurashi, T. F., Alam, R. I., Shaikh, S., & Tarkistani, M. A. M. (2025) · Journal of Nanotheranostics · doi:10.3390/jnt6020009 · Cited by 132
Bonincontro, G., Scuderi, S. A., Marino, A., & Simonetti, G. (2023) · Pharmaceuticals · doi:10.3390/ph16111531 · Cited by 91
Biofilm formation and antibiotic resistance in Pseudomonas aeruginosa
Haidar, A., Muazzam, A., Nadeem, A., Atique, R., Saeed, H. A., Naveed, A., Sharif, J., Perveen, A., Fatima, H. R., & Samad, A. (2024) · The Microbe · doi:10.1016/j.microb.2024.100078 · Cited by 85
Biofilms: structure, resistance mechanism, emerging control strategies, and applications
Ugwu, C. N., Ezeibe, E. N., Emencheta, S. C., Nwagwu, C. S., Ogbonna, K. O., Ejiofor, C. V., Onugwu, A. L., BEREBON, D. P., & Attama, A. A. (2025) · RSC Pharmaceutics · doi:10.1039/d5pm00094g · Cited by 72
Karampatakis, T., Tsergouli, K., & Behzadi, P. (2025) · Antibiotics · doi:10.3390/antibiotics14040353 · Cited by 69
Li, Z., Tang, J., Wang, X., Ma, X., Yuan, H., Gao, C., Guo, Q., Guo, X., Wan, J., & Dagot, C. (2025) · Microorganisms · doi:10.3390/microorganisms13092113 · Cited by 64
Advancing Nanotechnology: Targeting Biofilm-Forming Bacteria with Antimicrobial Peptides
Campos, J. V., de Pontes, J. T. C., Canales, C. S. C., Roque‐Borda, C. A., & Pavan, F. R. (2025) · BME Frontiers · doi:10.34133/bmef.0104 · Cited by 64
Coppola, F., Fratianni, F., Bianco, V., Wang, Z., Pellegrini, M., Coppola, R., & Nazzaro, F. (2025) · Microorganisms · doi:10.3390/microorganisms13051062 · Cited by 55
Biofilm, resistance, and quorum sensing: The triple threat in bacterial pathogenesis
Bhuiyan, M. N. I. (2025) · The Microbe · doi:10.1016/j.microb.2025.100578 · Cited by 50
Resistance mechanisms and therapeutic strategies for Pseudomonas aeruginosa infections
Meletis, G., & Karastergiou, E. (2025) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361251388382 · Cited by 31
Ullah, S., Chen, Y., Wu, C., Abbas, Y., Zhong, Y., Chen, X., Tan, J., Cheng, H., & Li, L. (2025) · RSC Advances · doi:10.1039/d5ra01711d · Cited by 25
Pawłuszkiewicz, K., Busłowicz, T., Korgiel, M., Faltus, A. M., Kucharczyk, E., Porębska, B., Pochciał, P., Kucharczyk, N., & Paluch, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178699 · Cited by 22
Ciobănaşu, C. (2025) · Antibiotics · doi:10.3390/antibiotics14040414 · Cited by 22
Wilson, R. M., Walker, J. M., Beld, J., & Yin, K. (2025) · Journal of Applied Microbiology · doi:10.1093/jambio/lxaf061 · Cited by 21
Priya, P. S., Meenatchi, R., Pasupuleti, M., Namasivayam, S. K. R., & Arockiaraj, J. (2025) · Current Microbiology · doi:10.1007/s00284-025-04091-7 · Cited by 21
Sathishkumar, P., & Khan, F. (2024) · Microbial Pathogenesis · doi:10.1016/j.micpath.2024.107103 · Cited by 21
Yang, Y., Xu, Z., Soteyome, T., Premarathna, M., Yin, X., & Liu, J. (2025) · Pharmaceuticals · doi:10.3390/ph18111688 · Cited by 20
Khan, F. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134533 · Cited by 20
Mohammed, R., Nader, S. M., Hamza, D. A., & Sabry, M. A. (2024) · Scientific Reports · doi:10.1038/s41598-024-77519-y · Cited by 19
Putri, S. A., Julaeha, E., Kagawa, N., & Kurnia, D. (2025) · Journal of Chemistry · doi:10.1155/joch/8838140 · Cited by 19
Habib, M. B., Batool, G., Shah, N. A., Muhammad, T., Akbar, N. S., & Shahid, A. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107497 · Cited by 18
Hasan, M. R., Rogers, W., Rahman, S., Muna, M. A., Rabu, K. F., & Hassan, S. (2025) · International Journal of Science and Research Archive · doi:10.30574/ijsra.2025.14.2.0340 · Cited by 18
Influence of menthol on membrane-associated properties of tetracycline-resistant Escherichia coli
Tadevosyan, S. K., & Sahakyan, N. Z. (2024) · AIMS Biophysics · doi:10.3934/biophy.2024018 · Cited by 16
Revolutionizing Antimicrobial Therapies Through Biofilm-Targeted Nanomedicine
Singh, R. (2025) · Current Pharmaceutical Research · doi:10.63785/cpr.2025.1.1.7897 · Cited by 16
Wang, F., Zhang, Y., Bassey, A. P., Singh, M., Zhu, Y., Corradini, M. G., Cui, X., Zhang, X., & Liu, X. (2024) · LWT · doi:10.1016/j.lwt.2024.115982 · Cited by 16
Abdullahi, I. N., Mejri, S., Okwume, C. C., Lawal, N. A., Olusegun, O. A., Sallem, R. B., & Slama, K. B. (2025) · Letters in Applied Microbiology · doi:10.1093/lambio/ovaf028 · Cited by 16
Bassey, A. P., Zhang, Y., Zhu, Y., Cui, X., Zhang, X., Corradini, M. G., Singh, M., Liu, X., & Zhang, H. (2023) · Innovative Food Science & Emerging Technologies · doi:10.1016/j.ifset.2023.103532 · Cited by 15
Bayat, M., Nahand, J. S., Farsad-Akhatr, N., & Memar, M. Y. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e22111 · Cited by 15
Mohamed, A. A., Elzayat, E. M., & El‐Shibiny, A. (2025) · Virology Journal · doi:10.1186/s12985-025-02848-x · Cited by 14
Distinct transcriptome and traits of freshly dispersed Pseudomonas aeruginosa cells
Kalia, M., & Sauer, K. (2024) · mSphere · doi:10.1128/msphere.00884-24 · Cited by 13
Boushra, M. R., Gad, G. F. M., Hassuna, N. A., Waly, N. G. F. M., & Ibrahem, R. A. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09605-5 · Cited by 12
Malik, A. K., Setia, A., Verma, D., Viswanadh, M. K., Mukherjee, A., & Muthu, M. S. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01883 · Cited by 12
Alsamhary, K. I. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107378 · Cited by 11
Núñez-García, L. Á., Córdova‐Fletes, C., Barboza‐Cerda, M. C., & Garza‐González, E. (2026) · BioMed Research International · doi:10.1155/bmri/5328382 · Cited by 11
Manika, M. M., Tano, A. K., Kapend’a, L. K., Mujing’a, F. M., Kakisingi, C. N., Matanda, S. K., Teta, I. M., Yves, M. B., Éric, K. I., Barhayiga, B. N., et al. (2025) · Annals of Clinical Microbiology and Antimicrobials · doi:10.1186/s12941-025-00811-w · Cited by 10
Bats as an Important Source of Antimicrobial-Resistant Bacteria: A Systematic Review
López, J. D. S., del Olmo, M. D., Fernández‐Soto, P., & Muro, A. (2024) · Antibiotics · doi:10.3390/antibiotics14010010 · Cited by 10
Resistome in the indoor dust samples from workplaces and households: a pilot study
Klvanova, E., Videnska, P., Bartoň, V., Bohm, J., Šplíchalová, P., Koksova, V., Urík, M., Lanickova, B., Prokeš, R., Budínská, E., et al. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1484100 · Cited by 10
Wang, L., Zheng, J., Hou, W., Zhang, C., Zhang, J., Fan, X., Zhang, H., & Han, Y. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074122 · Cited by 9
Brożyna, M., Stępnicka, Z., Tymińska, N., Dudek, B., Kapczyńska, K., Matkowski, A., Sun, Y., Tomczyk, M., & Junka, A. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1659096 · Cited by 8
Molecular Framework of Multidrug Resistance in Pseudomonas aeruginosa
Kannan, M., Jobby, R., Rajasekharan, S. K., Arya, R., & Ravichandran, V. (2025) · Current Microbiology · doi:10.1007/s00284-025-04610-6 · Cited by 7
Li, R., Zhu, X., Zhang, P., Wu, X., Jin, Q., & Pan, J. (2024) · Virulence · doi:10.1080/21505594.2024.2367649 · Cited by 7
Maravić-Vlahoviček, G., Kindl, M., Andričević, K., Obranić, S., & Vladimir‐Knežević, S. (2025) · Pharmaceuticals · doi:10.3390/ph18091269 · Cited by 7
Cecil, R. E., Ornelas, E., Phan, A., Medina-Chávez, N. O., Travisano, M., & Yoder-Himes, D. R. (2025) · Applied and Environmental Microbiology · doi:10.1128/aem.00975-25 · Cited by 7
Kumar, L., Patil, P., Bisen, M., Srivastava, N., & Thakur, D. (2024) · South African Journal of Botany · doi:10.1016/j.sajb.2024.08.052 · Cited by 6
Codon usage and antibiotic resistance: A hidden evolutionary mechanism
Dahal, U., & Bansal, A. (2025) · Biochimie · doi:10.1016/j.biochi.2025.07.027 · Cited by 6
Zarei, A., Gholami, A., Kanannejad, Z., Berenjian, A., Nabavizadeh, S. H., & Mohkam, M. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.71031 · Cited by 6
Phage steering in the presence of a competing bacterial pathogen
Czerwinski, S. M., & Gurney, J. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02882-24 · Cited by 6
Bianchi, M., Esin, S., Kaya, E., Batoni, G., & Maisetta, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137113 · Cited by 6
Gaballah, M. K., Khalid, S. A., Seleem, M. A., Bass, A. K. A., El-sherbiny, I. M., & Mayhoub, A. S. (2025) · RSC Advances · doi:10.1039/d5ra01831e · Cited by 6
Siroosi, M., & Jabalameli, F. (2024) · Current Microbiology · doi:10.1007/s00284-024-03799-2 · Cited by 5
Abdelmoneim, H. M., Alhudhaibi, A. M., Taha, R. H., Bendif, H., & Taha, T. H. (2026) · Infection · doi:10.1007/s15010-026-02817-8 · Cited by 5
David, A., Louis, M., Tahrioui, A., Rodrigues, S., Labbé, C., Maillot, O., Barreau, M., Lesouhaitier, O., Cornélis, P., Chevalier, S., et al. (2024) · Biofilm · doi:10.1016/j.bioflm.2024.100191 · Cited by 5
Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments
García, L. S., Roque‐Borda, C. A., Pavan, F. R., & Chorilli, M. (2026) · Apmis · doi:10.1111/apm.70166 · Cited by 5
Liu, W., Wang, Y., Sun, Y., Xia, W., Qian, X., Bo, R., Huang, Y., & Ruan, X. (2024) · Research in Veterinary Science · doi:10.1016/j.rvsc.2024.105291 · Cited by 5
Jantaruk, P., Teerapo, K., Charoenwutthikun, S., Roytrakul, S., & Kunthalert, D. (2024) · Antibiotics · doi:10.3390/antibiotics13080775 · Cited by 5
Ahmed, A. T. M. F., Mahmud, S., Khatun, M. T., Ali, M. F., Akter, M. R., & Mohiuddin, A. K. M. (2025) · Journal of Genetic Engineering and Biotechnology · doi:10.1016/j.jgeb.2025.100532 · Cited by 4
Samad, M. A. (2024) · Journal of Veterinary Medical and One Health Research · doi:10.36111/jvmohr.2023.5(1-2).0035 · Cited by 4
Breaking resistance: strategies for novel antibacterial therapeutic interventions
Saha, S., Rathour, S. P. S., Nair, G. G., Dey, A., & Srivastava, N. (2026) · Molecular Biology Reports · doi:10.1007/s11033-025-11402-5 · Cited by 4
Jiayu, T. I. A. N., Gong, Q., Shiji, Z. H. U., & Li, Y. (2023) · Journal of Veterinary Medical Science · doi:10.1292/jvms.23-0320 · Cited by 4
Rahman, M. S., & Wakeman, C. A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1791577 · Cited by 3
Abbad, I., Soulaimani, B., Miloudi, S., Hakioui, I. E., Drissi, B., Abbad, A., Sobeh, M., & Barakate, M. (2025) · LWT · doi:10.1016/j.lwt.2025.118665 · Cited by 3
Zhou, X., Cheng, J., Yang, X., & Sun, D. (2025) · Microbiological Research · doi:10.1016/j.micres.2025.128360 · Cited by 3
Phuong, N. Q., Thạch, P. N., & Giang, T. V. (2025) · IJID Regions · doi:10.1016/j.ijregi.2025.100709 · Cited by 3
Fernández-Billón, M., Jordana‐Lluch, E., Llambías-Cabot, A. E., Gomis-Font, M. A., Fraile-Ribot, P. A., Torrandell, R. I., Colman-Vega, P. J., Murillo, Ó., Macia, M. D., & Oliver, A. (2024) · Biofilm · doi:10.1016/j.bioflm.2024.100231 · Cited by 3
Self-citationThe Role of Pseudomonas aeruginosa in Surgical Site Infections in Sub-Saharan Africa
Kindiki, S., Nyongesa, P. K., Mogoi, N. N., & Kiprono, S. J. (2025) · Science Mundi · doi:10.51867/scimundi.5.1.2 · Cited by 3
Song, Y., Li, J., Zhang, Y., Su, L., Qin, S., Wu, C., & Song, G. (2025) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2025.107625 · Cited by 3
Charkhi, P., Haghshenas, M. R., Mirzaei, B., Khalili, Y., & Goli, H. R. (2024) · Health Science Reports · doi:10.1002/hsr2.70255 · Cited by 3
Bamb, A. L., Varma, S., Gade, T. S., Palaskar, S., Vamkudoth, K. R., Vyawahare, N., Chaudhari, P. M., & Chaudhari, B. P. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.108120 · Cited by 3
Jamal, A., Ullah, A., Jamal, T., Jamal, A., Muhammad, F., Ullah, S., Khan, S. A., Rehman, U., Ali, A., & Basit, A. (2024) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v7i11.1110 · Cited by 3
Mohammed, D. B., & Hasan, A. H. (2025) · UHD Journal of Science and Technology · doi:10.21928/uhdjst.v9n2y2025.pp92-100 · Cited by 3
Korzekwa, K., Kowalczyk-Chrząstowska, D., Szmurło, A., Wernecki, M., Ulatowska-Jarża, A., Buzalewicz, I., & Wojnicz, D. (2026) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-026-13719-y · Cited by 3
Maher, A. A. A., Maad, A. H., Al-Jaufy, A. Y., Al-Shami, H. Z., Al-Saban, A. M., Al-Haifi, A. Y., Al‐Worafi, Y. M., Al-Barq, A. M., Al-Yosffi, E. A. F. K., Saad, H. M., et al. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1762684 · Cited by 3
Lu, Z., He, B., Lei, Z., Wu, L., Ye, D., Xu, D., Cheng, S., Zhang, X., & Weng, Z. (2026) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2026.100574 · Cited by 2
Amer, M. A., Darwish, M. M., Monir, R., Taweel, A. A., Ghanem, A. I., Hanna, I. N., Hefnawy, A. H., Gebreel, N. S., Soltan, N. M., Aboudewan, Y. H., et al. (2026) · BMC Microbiology · doi:10.1186/s12866-026-05145-x · Cited by 2
Breaking the Toxicity-Efficacy Dilemma of Polymyxins: Advances in Synergists
Cai, Z., Zhang, Y., Xin, Y., Han, L., Xu, B., Du, M., & Zhao, Y. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.5c00782 · Cited by 2
Microbial contamination levels in water derived from dental units used in small animal dentistry
Šparaš, L., Nemec, A., & Biasizzo, M. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1639712 · Cited by 2
Henaish, A., & Alwashaish, M. M. (2025) · AlQalam Journal of Medical and Applied Sciences · doi:10.54361/ajmas.258481 · Cited by 2
Jana, S., Malhotra, A., Mittal, H., Chakraborty, S., Khanuja, M., Singh, G., Karan, R., Rozhina, E. V., & Chauhan, A. (2025) · Pharmaceuticals · doi:10.3390/ph19010055 · Cited by 2
Mulat, M., Tabassum, N., Kim, T., & Khan, F. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-026-04850-z · Cited by 2
Badawy, A. E., Hamza, D. A., Ahmed, Z., & Sabry, M. A. (2026) · BMC Veterinary Research · doi:10.1186/s12917-026-05532-6 · Cited by 2
Kordmahaleh, N. P., Mirpour, M., Ranji, N., Shahriarinour, M., & Nikpassand, M. (2025) · 3 Biotech · doi:10.1007/s13205-025-04371-w · Cited by 2
Ojha, B., Grosz, K., & Rojas, C. M. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.02669-25 · Cited by 2
Ma, F., Jiang, Q., Gu, J., Xiao, Y., Xing, Z., Guo, Y., Zhao, P., Qing, W., Khan, Z. H., Dai, F., et al. (2026) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2026.154026 · Cited by 2
Key phenotypic mechanisms underpinning biofilm antimicrobial resistance
Sun, Y., & Qu, Y. (2025) · Microbiology Australia · doi:10.1071/ma25057 · Cited by 2
Infection Prevention and Control in the Intensive Care Unit
Decker, B. K., & O’Donnell, M. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2025.12.010 · Cited by 1
Unveiling hidden variables in stressed bacteria
Choudhary, D., & Vincent, M. S. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.116966 · Cited by 1
Antimicrobial Resistance and Modern Therapeutics Approaches
(2025) · Frontiers research topics · doi:10.3389/978-2-8325-6077-8 · Cited by 1
Majidi, S., Zaboli, F., Khoshbakht, R., Fattahi, E., & Khosravi, M. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102409 · Cited by 1
Genetic potential for biofilm formation of clinical strains of Pseudomonas aeruginosa
Немченко, У. М., Belkova, N. L., Станиславовна, К. Е., Евгеньевна, С. Н., Евгеньевна, З. Р., Sinkov, V. V., & Савилов, Е. Д. (2025) · Vavilov Journal of Genetics and Breeding · doi:10.18699/vjgb-25-62 · Cited by 1
Chaitanya, K. S., Yu, T. T., Chaudhari, H. S., Orekonday, N., Kumar, N., Dey, R. J., Murugesan, S., & Sekhar, K. V. G. C. (2026) · Archiv der Pharmazie · doi:10.1002/ardp.70209 · Cited by 1
Qiu, F., Fan, C., Tang, Q., Chandarajoti, K., Wang, X., Zhang, K., Ye, W., Wang, C. X., & Zhou, W. (2026) · Phytotherapy Research · doi:10.1002/ptr.70235 · Cited by 1
Multidrug-Resistant Pseudomonas aeruginosa in Nosocomial Infections
Oyeniran, K. A., Lawal, A. M., Oyeniran, O. H., Olowe, B. M., & Donaldson, L. (2026) · IGI Global eBooks · doi:10.4018/979-8-3373-3825-5.ch006 · Cited by 1
Faiza, I., Haci, I. A. E., Elghali, F., Mrabet, R., Aifa, S., & Mnif, S. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2588794 · Cited by 1
TAKAHASHI, M., & Shimooki, O. (2025) · Infection Disease & Health · doi:10.1016/j.idh.2025.10.001 · Cited by 1
Barba‐Ostria, C., Mayorga-Ramos, A., Zúñiga-Miranda, J., González‐Pastor, R., Coyago-Cruz, E., Viteri, A., Peñaherrera, A., Hernández, O. D. L., Celi, D., Tejera, E., et al. (2026) · Molecules · doi:10.3390/molecules31111925 · Cited by 1
Creation of Pyocin Composition Against Laboratory and Clinical Pseudomonas aeruginosa Strains
Bаlko, O. B., Balko, O. I., Shelkova, N. G., Voitsekhovsky, V. G., & Avdeeva, L. V. (2025) · Mikrobiolohichnyi Zhurnal · doi:10.15407/microbiolj87.02.071 · Cited by 1
Uka, E., Fatunla, O. K., Nelson, V. A., Udosen, C. I., & Ugor, M. A. (2025) · GSC Biological and Pharmaceutical Sciences · doi:10.30574/gscbps.2025.32.1.0247 · Cited by 1
Hering-Peter, C., Westphal, J., & Schulz, R. (2026) · Journal of Applied Phycology · doi:10.1007/s10811-026-03813-z · Cited by 1
INVESTIGATING BIOFILM FORMATION AND QUORUM SENSING IN UROPATHOGENIC E. COLI UNDER STRESS CONDITIONS
Shafique, M. (2024) · Biology and Biotechnology Communications · doi:10.67079/bbc.0220 · Cited by 1
Metadata
- Authors
- Fernández-Billón, M., Llambías-Cabot, A. E., Jordana-Lluch, E., Oliver, A., & Macià, M. D.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Venue
- Biofilm
- Publisher
- Elsevier BV
- Published
- 2023-12
- Volume
- 5
- Pages
- 100129
- ISSN
- 2590-2075 (ISSN-L)
- PMC
- PMC10189392
- OpenAlex
- W4367693161
- Cited by
- 170
- References
- 136
- Citations by year
- 2026: 65 · 2025: 64 · 2024: 34 · 2023: 7
- FWCI
- 11.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- Locations
- Biofilm (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Docusalut (Conselleria de Salut i Consum del Govern de les Illes Balears) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Hispana (submittedVersion, cc-by-nc-nd)
- Funders
- Instituto de Salud Carlos III
- Ministerio de Ciencia e Innovación
- Centro de Investigación Biotecnológica en Red de Enfermedades Infecciosas (2322/2746)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Bacterial Genetics and Biotechnology
- Keywords
- Pseudomonas aeruginosa, biofilm, antibiotic resistance, spontaneous mutation rate, chronic infection, chronic lung infection, antimicrobial therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-11-22, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-22 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
![Fig. 1 Mechanisms of antimicrobial tolerance and resistance found in biofilms and antibiotics affected by them. FQ: Fluoroquinolones; AMG: Aminoglycosides; AZT: Azitromycin; LPS: lipopolysaccharide. Figure adapted from Ciofu O et al., Nat rev, 2022 [62].](https://figures.cochat.ai/paper-figures/9868f8e636334ecababe5458f56b6d16/mechanisms-of-antibiotic-resistance-in-pseudomonas-aeruginosa-biofilms-figure-1.jpg)